EVN AG (0EEI)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 29.53 |
|---|---|
| 52-week range | 23.66 – 30.45 |
| Return, 1 month / 3 months | +1.6% / +0.1% |
| Return, 1 year / 3 years | +22.3% / +30.6% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 20.1% |
| Worst drawdown (1 year) | -8.0% |
| Average daily value traded | 0.39M EUR |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
EVN AG is an Austrian energy utility based in Maria Enzersdorf, Lower Austria. It supplies electricity, natural gas, heat and water to households, businesses and municipalities, mainly in its home region and neighbouring countries. The company generates power, including from hydroelectric plants, and operates the networks that carry energy to its customers. It also provides related services such as waste management and drinking water supply, serving both private and commercial users across its markets.
EVN AG trades under the code 0EEI on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
EVN AG (0EEI) trades on the London Exchange in UK. It last closed at EUR 29.53 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 788 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.3% and over the last three months it rose 0.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.4% | ||
| From 52-week high | -2.6% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.1% | ||
| 6-month return | 5.3% | ||
| 12-month return, skipping the last month | 20.3% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -8.0% | ||
| Liquidity | 43 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.39M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +1.6% |
| 3 months | +0.1% |
| 6 months | +5.3% |
| 1 year | +22.3% |
| 3 years | +30.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 28.77 / 28.56 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Mar 2026 | EUR 0.9000 |
| 3 Mar 2025 | EUR 0.9000 |
| 6 Feb 2024 | EUR 0.6200 |
| 7 Feb 2023 | EUR 0.5200 |
| 9 Feb 2022 | EUR 0.5200 |
| 27 Jan 2021 | EUR 0.4900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.